PubMed

Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.

Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, Moltrasio M, Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL.

Ann Intern Med. 2009 Feb 3;150(3):170-7.PMID: 19189906 [PubMed - indexed for MEDLINE]Related articlesFree article

Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL.

J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5.PMID: 15519007 [PubMed - indexed for MEDLINE]Related articles

Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Kowalczyk J, Lenarczyk R, Kowalski O, Swiatkowski A, Stabryła-Deska J, Kurek T, Honisz G, Kukulski T, Gasior M, Kalarus Z.

Kardiol Pol. 2007 Jun;65(6):635-43; discussion 644.PMID: 17629825 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.

Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, Chu J, Yan J, Zhang R, Kwan TW.

Int J Cardiol. 2008 Jun 6;126(3):407-13. Epub 2007 Jul 24.PMID: 17651830 [PubMed - indexed for MEDLINE]Related articles

Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.

Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, Plehn G, Trappe HJ, Meissner A.

Clin Res Cardiol. 2009 Oct 23. [Epub ahead of print]PMID: 19851800 [PubMed - as supplied by publisher]Related articles

[Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography]

Jujo K, Yamaguchi J, Obayashi K, Suzuki K, Sekiguchi H, Nagashima M, Tsurumi Y, Kasanuki H.

J Cardiol. 2006 Jul;48(1):9-16. Japanese. PMID: 16886495 [PubMed - indexed for MEDLINE]Related articles

Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.

Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.

J Coll Physicians Surg Pak. 2005 Dec;15(12):791-4.PMID: 16398973 [PubMed - indexed for MEDLINE]Related articles

Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.

Nyman U, Björk J, Aspelin P, Marenzi G.

Acta Radiol. 2008 Jul;49(6):658-67.PMID: 18568558 [PubMed - indexed for MEDLINE]Related articles

A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.

Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, Boura J, Aboufares A, Sporn D, Stapleton D.

Am J Cardiol. 2008 Mar 15;101(6):812-9. Epub 2008 Jan 14.PMID: 18328846 [PubMed - indexed for MEDLINE]Related articles

Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.

Jabara R, Gadesam RR, Pendyala LK, Knopf WD, Chronos N, Chen JP, Viel K, King SB 3rd, Manoukian SV.

Am J Cardiol. 2009 Jun 15;103(12):1657-62. Epub 2009 Apr 16.PMID: 19539072 [PubMed - indexed for MEDLINE]Related articles

Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose.

Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M; Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Am J Cardiol. 2002 Nov 15;90(10):1068-73.PMID: 12423705 [PubMed - indexed for MEDLINE]Related articles

Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.

Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB.

J Invasive Cardiol. 2003 Jan;15(1):18-22.PMID: 12499523 [PubMed - indexed for MEDLINE]Related articles

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL.

N Engl J Med. 2006 Jun 29;354(26):2773-82.PMID: 16807414 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.

Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):958-65.PMID: 19021282 [PubMed - indexed for MEDLINE]Related articles

Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.

McCullough P.

Catheter Cardiovasc Interv. 2006 Mar;67(3):335-43. Review.PMID: 16489569 [PubMed - indexed for MEDLINE]Related articles

Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.

J Am Coll Cardiol. 2008 Aug 19;52(8):599-604.PMID: 18702961 [PubMed - indexed for MEDLINE]Related articles

Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.

Kini AS, Sarkar K, Rafael OC, Jakkula M, Kaplish D, Lee P, Suleman J, Krishnan P, Kim MC, Sharma SK.

Catheter Cardiovasc Interv. 2009 Jul 1;74(1):49-55.PMID: 19288579 [PubMed - indexed for MEDLINE]Related articles

Risk score for contrast induced nephropathy following percutaneous coronary intervention.

Ghani AA, Tohamy KY.

Saudi J Kidney Dis Transpl. 2009 Mar;20(2):240-5.PMID: 19237811 [PubMed - indexed for MEDLINE]Related articlesFree article

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.

Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Jun 1;101(11):1544-9. Epub 2008 Apr 18.PMID: 18489931 [PubMed - indexed for MEDLINE]Related articles

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.PMID: 14661012 [PubMed - indexed for MEDLINE]Related articles